Integrin: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 65: | Line 65: | ||
**[[4a0q]] - hIG I domain (mutant) + Mg<br /> | **[[4a0q]] - hIG I domain (mutant) + Mg<br /> | ||
**[[2l8s]] - hIG transmembrane domain – NMR<BR /> | **[[2l8s]] - hIG transmembrane domain – NMR<BR /> | ||
**[[5hgj]] - hIG VWFA domain<br /> | |||
**[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | **[[1mhp]] - rIG I domain (mutant) + antibody + Mn<br /> | ||
**[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | **[[2b2x]] - rIG I domain (mutant) + antibody + Mg<br /> | ||
| Line 71: | Line 72: | ||
*IG α-2 (CD49b) | *IG α-2 (CD49b) | ||
**[[4bj3]], [[5e6x]], [[5e6v]] - hIG I domain<br /> | |||
**[[1dzi]], [[4bj3]] - hIG I domain + collagen peptide<br /> | **[[1dzi]], [[4bj3]] - hIG I domain + collagen peptide<br /> | ||
**[[1v7p]] - hIG I domain (mutant) + EMS16 + Mn<br /> | **[[1v7p]] - hIG I domain (mutant) + EMS16 + Mn<br /> | ||
| Line 97: | Line 99: | ||
**[[1tye]], [[3fcu]], [[3fcs]] – hIG + Mg<br /> | **[[1tye]], [[3fcu]], [[3fcs]] – hIG + Mg<br /> | ||
**[[3fc3]] – hIG (mutant) + Mg<br /> | **[[3fc3]] – hIG (mutant) + Mg<br /> | ||
**[[2vc2]], [[2vdk]], [[2vdl]], [[3nid]], [[3nif]], [[3nig]], [[3zdx]], [[3zdy]], [[3zdz]], [[3ze0]], [[3ze1]], [[3ze2]] – hIG headpiece + antibody + Mg<br /> | **[[2vc2]], [[2vdk]], [[2vdl]], [[3nid]], [[3nif]], [[3nig]], [[3zdx]], [[3zdy]], [[3zdz]], [[3ze0]], [[3ze1]], [[3ze2]], [[5hdb]] – hIG headpiece + antibody + Mg<br /> | ||
**[[4z7q]], [[4z7o]], [[4z7n]] – hIG headpiece + antibody + Mg + tetrapeptide<br /> | |||
**[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | **[[2vdm]], [[2vdn]], [[3t3m]], [[3t3p]] – hIG headpiece + antibody + antagonist + Mg<br /> | ||
**[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | **[[2vdo]], [[2vdp]], [[2vdq]], [[2vdr]] – hIG headpiece + antibody + fibrinogen peptide + Mg<br /> | ||
| Line 130: | Line 133: | ||
**[[4um8]] – hIG headpiece (mutant) + Ni<br /> | **[[4um8]] – hIG headpiece (mutant) + Ni<br /> | ||
**[[5ffg]] – hIG headpiece + Ca<br /> | |||
**[[4um9]] – hIG headpiece (mutant) + Mg + transforming growth factor β 3<br /> | **[[4um9]] – hIG headpiece (mutant) + Mg + transforming growth factor β 3<br /> | ||
| Line 135: | Line 139: | ||
**[[4ixd]] – hIG I domain<br /> | **[[4ixd]] – hIG I domain<br /> | ||
**[[5e6s]], [[5e6r]] – hIG AI, headpiece,pocket domains + Mg<br /> | |||
**[[2m3e]] – hIG transmembrane domain - NMR<br /> | **[[2m3e]] – hIG transmembrane domain - NMR<br /> | ||
*IG α-L β-2 | |||
**[[5e6u]] – hIG headpiece (mutant) + Ni<br /> | |||
*IG α-M | *IG α-M | ||
| Line 142: | Line 151: | ||
**[[4m76]] – hIG + complement C3<br /> | **[[4m76]] – hIG + complement C3<br /> | ||
**[[2lke]], [[2lkj]] – hIG cytoplasmic domain – NMR<BR /> | **[[2lke]], [[2lkj]] – hIG cytoplasmic domain – NMR<BR /> | ||
**[[4xw2]] – hIG + simvastatin<br /> | |||
*IG α-X | *IG α-X | ||
| Line 149: | Line 159: | ||
*IG α-X β-2 (CD18) | *IG α-X β-2 (CD18) | ||
**[[3k6s]], [[3k71]], [[3k72]] – hIG + Mg<br /> | **[[3k6s]], [[3k71]], [[3k72]], [[5es4]] – hIG + Mg<br /> | ||
**[[4neh]], [[4nen]] – hIG (mutant) + Mg<br /> | **[[4neh]], [[4nen]] – hIG (mutant) + Mg<br /> | ||
